Publications dans lesquelles il/elle collabore avec Pilar Matía Martín (20)

2023

  1. How Did the COVID-19 Lockdown Pandemic Affect the Depression Symptomatology in Mediterranean Older Adults with Metabolic Syndrome?

    Depression and Anxiety, Vol. 2023

  2. Impact of COVID-19 pandemic on the PREDIMED-Plus randomized clinical trial: Effects on the interventions, participants follow-up, and adiposity

    Frontiers in Nutrition, Vol. 9

  3. Ultra-processed foods consumption as a promoting factor of greenhouse gas emissions, water, energy, and land use: A longitudinal assessment

    Science of the Total Environment, Vol. 891

2022

  1. Association between the Prime Diet Quality Score and depressive symptoms in a Mediterranean population with metabolic syndrome. Cross-sectional and 2-year follow-up assessment from PREDIMED-PLUS study

    British Journal of Nutrition, Vol. 128, Núm. 6, pp. 1170-1179

  2. Factors associated with successful dietary changes in an energy-reduced Mediterranean diet intervention: a longitudinal analysis in the PREDIMED-Plus trial

    European Journal of Nutrition, Vol. 61, Núm. 3, pp. 1457-1475

  3. One-year changes in fruit and vegetable variety intake and cardiometabolic risk factors changes in a middle-aged Mediterranean population at high cardiovascular risk

    European Journal of Clinical Nutrition, Vol. 76, Núm. 10, pp. 1393-1402

  4. Pro-vegetarian food patterns and cardiometabolic risk in the PREDIMED-Plus study: a cross-sectional baseline analysis

    European Journal of Nutrition, Vol. 61, Núm. 1, pp. 357-372

2021

  1. Association between coffee consumption and total dietary caffeine intake with cognitive functioning: cross-sectional assessment in an elderly Mediterranean population

    European Journal of Nutrition, Vol. 60, Núm. 5, pp. 2381-2396

  2. Fruit consumption and cardiometabolic risk in the PREDIMED-plus study: A cross-sectional analysis

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1702-1713

  3. High fruit and vegetable consumption and moderate fat intake are associated with higher carotenoid concentration in human plasma

    Antioxidants, Vol. 10, Núm. 3, pp. 1-14

2020

  1. Carbohydrate quality changes and concurrent changes in cardiovascular risk factors: A longitudinal analysis in the PREDIMED-Plus randomized trial

    American Journal of Clinical Nutrition, Vol. 111, Núm. 2, pp. 291-306

  2. Cross-sectional association between non-soy legume consumption, serum uric acid and hyperuricemia: the PREDIMED-Plus study

    European Journal of Nutrition, Vol. 59, Núm. 5, pp. 2195-2206

  3. Dietary polyphenol intake is associated with HDL-cholesterol and a better profile of other components of the metabolic syndrome: A PREDIMED-plus sub-study

    Nutrients, Vol. 12, Núm. 3

  4. Health-related quality of life in individuals with metabolic syndrome: A cross-sectional study

    Semergen: revista española de medicina de familia, Núm. 8, pp. 524-537

  5. Relationship between olive oil consumption and ankle-brachial pressure index in a population at high cardiovascular risk

    Atherosclerosis, Vol. 314, pp. 48-57

2019

  1. Cohort profile: Design and methods of the PREDIMED-Plus randomized trial

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 387-388o

  2. Long daytime napping is associated with increased adiposity and type 2 diabetes in an elderly population with metabolic syndrome

    Journal of Clinical Medicine, Vol. 8, Núm. 7

2018

  1. Effectiveness of the physical activity intervention program in the PREDIMED-Plus study: A randomized controlled trial 11 Medical and Health Sciences 1117 Public Health and Health Services

    International Journal of Behavioral Nutrition and Physical Activity, Vol. 15, Núm. 1

  2. Fermented dairy products, diet quality, and cardio–metabolic profile of a Mediterranean cohort at high cardiovascular risk

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 28, Núm. 10, pp. 1002-1011

  3. Mediterranean diet and quality of life: Baseline cross-sectional analysis of the PREDIMED-PLUS trial

    PLoS ONE, Vol. 13, Núm. 6